some seriously good red hearts were dabbling in SL1(SLone) the other day so I thought I would take a lot.
sometimes you just have to stick to your guns. Like BOT.
I dint like SL1 but I did read something quite interesting today about NEU. I believe they are doing or have done stage 2 trials in usa on a condition neurological called retts disease. it all seems to be going quite well. they have a MC of $314million.
Hello BOT.
If phase one works out well - results May this year - then surely phase 2 will as well. This aint no injectable or ingestible ingredient here so surely phase 1 makes phase 2 a no brainer.
Then phase three. more people, etc etc. Hello $300 million.
Just my ideas. Partner with a bigger pharmaceutical crowd as well to do phase 2 or run with it themselves. probably could not afford it but with matts contacts, this should be easy.
Its had a nice 5 to 8c run but it like see ya later is massively undervalued. BOT more so.
We wait.
SDX Price at posting:
12.0¢ Sentiment: Hold Disclosure: Held
